Growth Capital • Construction

Andera Partners Invests In Terideal

On February 16, 2010, private equity firm Andera Partners invested in construction company Terideal

Investment Context
  • This is Andera Partners’ 1st transaction in the Construction sector.
  • This is Andera Partners’ 2nd transaction in France.
Investment Fate
  • Terideal was sold to a consortium of financial buyers in 2017.

Explore All 171 Growth Capital Construction Deals - Search the Database Free


Investment Summary

Date February 16, 2010
Target Terideal
Sector Construction
Investor(s) Andera Partners
Deal Type Growth Capital

Target Company

Terideal

Wissous, France
Terideal develops civil works and urban planning. Terideal was founded in 1969 and is based in Wissous, France.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

Andera Partners

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2001
PE ASSETS 3.7B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

Andera Partners is a private investment firm focused on several strategies. The Firm invests in life science opportunities through its BioDiscovery group. The Firm invests in Western European small to mid-sized companies (€30 to €300 million of revenue) through its Winch Capital group. Andera invests in small to mid-sized French companies (€10 to €100 million of revenue) through its Cabestan Capital team. Andera invests in €5 to €45 million of mezzanine capital to support small to mid-sized French companies. Andera Partners was established in 2001 and is headquartered in Paris.


Deal Context for Investor #
Overall 7 of 123
Sector: Construction 1 of 6
Type: Growth Capital 2 of 26
Country: France 2 of 86
Year: 2010 1 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-11-02 Vivoryon Therapeutics

Halle, Germany

Vivoryon Therapeutics is a biopharmaceutical company focused on the development and commercialisation of new therapeutic products for the treatment of alzheimer’s disease (“AD”). Vivoryon Therapeutics was founded in 1997 and is based in Halle, Germany.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-03-05 Nexira

Rouen, France

Nexira has been providing innovative natural ingredients for the food, health and nutrition industries. Nexira was founded in 1895 and is based in Rouen, France.

Buy -

Explore Related M&A Activity